Database

Startups

Main Industry
Biotechnology
Main Product/Service
Currently focused on retinal organoid development, providing:
Retinal organoid samples suitable for bulk production
Quality validation reports including structural metrics
Founded Year
2020
Unified Business No.
83464716
Status
Active
Number of Employees
0
Total Paid-in Capital
11,600,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
PlasmonicTron, founded in 2020, develops multimodal intelligent bioprocessing technologies integrating biomolecular force monitoring, bioimaging, and microfluidics. The company has created an AI-powered automated organoid production platform capable of large-scale retinal organoid cultivation. Its fully automated culture system enables expert-level, continuous organoid cultivation for complex, long-term, and multi-cell-type environments, advancing organoid R&D toward semiconductor-level precision and scalability.



More ↓

Similar Companies

Insilico Medicine Taiwan Limited

Insilico’s flagship suite includes PandaOmics (multi-omics target identification), Chemistry42 (de novo molecular design), and InClinico (clinical outcome prediction). By leveraging these AI modules, they can rapidly generate novel molecules, predict safe

SYNCELL (TAIWAN) INC.

SYNCELL’s flagship technology is the Microscoop™ system — a high-content, microscope-based platform that couples AI-driven image recognition with proprietary photosensitive labeling reagents to tag and selectively isolate proteins and nucleic acids from u

擴核生醫科技股份有限公司

Touchstone DX Laboratory Automation Solution integrates incubators, microscopes, centrifuges, and other laboratory equipment into a single compact unit. The device is lightweight and approximately the size of a shoebox. Through the design of 3D fluid cartridges and a multi-dimensional control system, researchers can customize automated experimental workflows. The system automatically performs various experiments based on the researcher’s settings, such as adding reagents to control liquid flow or using the microscope to monitor cell activity changes. This solution aims to help small and medium-sized biomedical and pharmaceutical laboratories increase drug development efficiency while reducing costs.